A Retrospective Analysis: Whether Five Factors Affect PFS in Patients With Locally Advanced Cervical Cancer

NCT05779111 | Completed

• 1 other identifier: CQGOG0111
• Study Type: observational
• Target: 183
• Locations: 1 country
• Sites: 1

Brief Summary

In previous studies, the investigators found that five factors were effective in predicting the probability of locally advanced cervical cancer with para-aortic lymph node metastasis.A retrospective study was conducted to explore the influence of 5 factors on PFS in patients with locally advanced cervical cancer receiving radiotherapy and chemotherapy.

Conditions

Locally Advanced Cervical Cancer; Radiotherapy

Outcome Measures

Primary Outcomes (1)

• Progression Free Survival（PFS）

  Whether there are differences in PFS between the two groups

  3 months

Study Arms (2)

Scores greater than or equal to 3 in patients with locally advanced cervical cancer

Scores greater than or equal to 3 in patients with locally advanced cervical cancer

Patients with locally advanced cervical cancer scored less than 3 points

Patients receiving radiotherapy for locally advanced cervical cancer were scored according to five factors, with a score of less than 3

Eligibility Criteria

• Age: 18 Years - 70 Years
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

From May 2016 to July 2021, 183 patients with locally advanced cervical cancer received radiotherapy in our hospital ,with or without chemotherapy.Patients were scored according to 5 factors. PFS were compared between patients with scores greater than or equal to 3 points and those with scores less than 3 points. PFS is defined as the time from the end of treatment to disease progression or the time of the last follow-up 2022-10-01.

Locally advanced cervical cancer patients receiving radiotherapy

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

• Chongqing University Cancer Hospital: lead

Study Sites (1)

Chongqing Cancer Hospital

Chongqing, Chongqing Municipality, 400030, China

Location

Study Officials

• Zou Dongling, M.D.

  Chongqing University Cancer Hospital Chongqing, Chongqing, China,

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 19, 2023
• First Posted: March 22, 2023
• Study Start: February 10, 2022
• Primary Completion: November 1, 2022
• Study Completion: December 10, 2022
• Last Updated: March 22, 2023

Record last verified: 2023-02

Data Sharing

• IPD Sharing: Will not share

Locations

CN (1)